Showing results (131-140 of 246) with videos related to
Sort By:
Pageof 25
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 8, 2021
Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosisAdinarayana Nandikolla, Singireddi Srinivasarao, Yogesh Mahadu Khetmalis, et al.Archiv Der Pharmazie|December 3, 2022
Synthesis, antimycobacterial, cytotoxicity, anti-inflammatory, in silico studies and molecular dynamics of pyrazole-embedded thiazolidin-4-one hybridsVinuta Kamat, Boja Poojary, Divyaraj Puthran, et al.ACS Infectious Diseases|June 30, 2022
Optimization of Benzoxazinorifamycins to Improve <i>Mycobacterium tuberculosis</i> RNA Polymerase Inhibition and Treatment of TuberculosisWalajapet Rajeswaran, Shireen R Ashkar, Pil H Lee, et al.Journal of Natural Products|February 10, 2010
Bioactive bromophycolides R-U from the Fijian red alga Callophycus serratusAn-Shen Lin, E Paige Stout, Jacques Prudhomme, et al.Journal of Natural Products|March 7, 2023
Isolation and Characterization of Anti-Mycobacterial Natural Products from a <i>Petrosia</i> sp. Marine SpongeBhuwan Khatri Chhetri, Riya Bhanushali, Yifan Liang, et al.The Journal of Organic Chemistry|February 23, 2019
Quality Control of Therapeutic Peptides by <sup>1</sup>H NMR HiFSA SequencingMary P Choules, Jonathan Bisson, Wei Gao, et al.Bioorganic & Medicinal Chemistry Letters|March 9, 2025
Exploration of quinoxaline triazoles as antimycobacterial agents: design, synthesis and biological evaluationBoddupalli Venkata Siva Kumar, Mahesh Kumar Talamadla, Adinarayana Nandikolla, et al.Tetrahedron Letters|February 10, 2022
Synthetic studies towards isomeric pyrazolopyrimidines as potential ATP synthesis inhibitors of <i>Mycobacterium tuberculosis</i>. Structural correction of reported <i>N</i>-(6-(2-(dimethylamino)ethoxy)-5-fluoropyridin-3-yl)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrazolo[1,5-<i>α</i>]pyrimidin-7-aminePeter J Choi, Guo-Liang Lu, Hamish S Sutherland, et al.Journal of Medicinal Chemistry|November 13, 2010
Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Iveta Kmentova, Hamish S Sutherland, Brian D Palmer, et al.Journal of Medicinal Chemistry|March 18, 2015
Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Brian D Palmer, Hamish S Sutherland, Adrian Blaser, et al.Pageof 25